PD-L1 is expressed by tumor cells, bringing about the continuous activation of the PD-1/PD-L1 signaling pathway in the tumor microenvironment, in which negative feedback inhibits the activity of T/B lymphocytes, thereby mediating the occurrence of immune escape from tumor cells (125–127). This evidence concerns the gene CD274 and neoplasm.